Literature DB >> 29079189

Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer.

Yunshu Lu1, Yipeng Yang1, Yan Liu2, Yajuan Hao1, Yijian Zhang1, Yunping Hu1, Lin Jiang1, Yurong Gong1, Kejin Wu3, Yingbin Liu4.   

Abstract

C-terminal Src kinase (Csk)-binding protein (Cbp) is a ubiquitously expressed transmembrane adaptor protein which regulating Src family kinase (SFK) activities. Although SFKs are well known for their involvement in breast cancer, the function of Cbp in breast carcinogenesis upon the adipose-tumor microenvironment has not been investigated. Here, we reported that adipose-derived mesenchymal stem cells (ASCs) induced increased expression of Cbp accompanied by enhanced cell proliferation and chemotherapy resistance in breast cancer cell MCF-7/ADR. Depletion of Cbp in breast cancer cell by RNA interference led to remarkable inhibition of cell proliferation, invasion as well as synergy with adriamycin hydrochloride to suppress the tumor growth. Furthermore, silencing of Cbp concomitantly inhibited the expression of phosphoryl of Src, AKT and mTOR signals. Our study highlights the underlying mechanism of cross interaction between ASCs and breast cancer cells, and indicates that PAG1/Cbp in breast cancer cell may modulate tumor progression and acquired chemoresistance in the ASCs-associated breast cancer microenvironment through Src and AKT/mTOR pathways.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASCs; Breast cancer; Chemoresistance; PAG1/Cbp; Src

Mesh:

Substances:

Year:  2017        PMID: 29079189     DOI: 10.1016/j.bbrc.2017.10.118

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance.

Authors:  Fei Su; Songyeon Ahn; Achinto Saha; John DiGiovanni; Mikhail G Kolonin
Journal:  Oncogene       Date:  2018-10-25       Impact factor: 9.867

Review 2.  Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.

Authors:  Jana Plava; Marina Cihova; Monika Burikova; Miroslava Matuskova; Lucia Kucerova; Svetlana Miklikova
Journal:  Mol Cancer       Date:  2019-03-30       Impact factor: 27.401

Review 3.  Impact of the Different Preparation Methods to Obtain Human Adipose-Derived Stromal Vascular Fraction Cells (AD-SVFs) and Human Adipose-Derived Mesenchymal Stem Cells (AD-MSCs): Enzymatic Digestion Versus Mechanical Centrifugation.

Authors:  Pietro Gentile; Claudio Calabrese; Barbara De Angelis; Jacopo Pizzicannella; Ashutosh Kothari; Simone Garcovich
Journal:  Int J Mol Sci       Date:  2019-11-02       Impact factor: 5.923

Review 4.  Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells.

Authors:  Taja Železnik Ramuta; Mateja Erdani Kreft
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

Review 5.  Combination Approaches to Target PD-1 Signaling in Cancer.

Authors:  Emily K Moore; Marianne Strazza; Adam Mor
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.